Expanding the Molecular and Clinical Phenotype of SSR4-CDG

University of Washington Center for Mendelian Genomics

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Congenital disorders of glycosylation (CDG) are a group of mostly autosomal recessive disorders primarily characterized by neurological abnormalities. Recently, we described a single CDG patient with a de novo mutation in the X-linked gene, Signal Sequence Receptor 4 (SSR4). We performed whole-exome sequencing to identify causal variants in several affected individuals who had either an undifferentiated neurological disorder or unsolved CDG of unknown etiology based on abnormal transferrin glycosylation. We now report eight affected males with either de novo (4) or inherited (4) loss of function mutations in SSR4. Western blot analysis revealed that the mutations caused a complete loss of SSR4 protein. In nearly all cases, the abnormal glycosylation of serum transferrin was only slightly above the accepted normal cutoff range.

Original languageEnglish (US)
Pages (from-to)1048-1051
Number of pages4
JournalHuman Mutation
Volume36
Issue number11
DOIs
StatePublished - Nov 1 2015

Fingerprint

Congenital Disorders of Glycosylation
Transferrin
Phenotype
Glycosylation
Mutation
Exome
X-Linked Genes
Nervous System Diseases
Reference Values
Western Blotting
Serum
signal sequence receptor

Keywords

  • Carbohydrate-deficient transferrin
  • Congenital disorders of glycosylation
  • Signal sequence receptor 4
  • SSR4
  • Translocon complex

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

University of Washington Center for Mendelian Genomics (2015). Expanding the Molecular and Clinical Phenotype of SSR4-CDG. Human Mutation, 36(11), 1048-1051. https://doi.org/10.1002/humu.22856

Expanding the Molecular and Clinical Phenotype of SSR4-CDG. / University of Washington Center for Mendelian Genomics.

In: Human Mutation, Vol. 36, No. 11, 01.11.2015, p. 1048-1051.

Research output: Contribution to journalArticle

University of Washington Center for Mendelian Genomics 2015, 'Expanding the Molecular and Clinical Phenotype of SSR4-CDG', Human Mutation, vol. 36, no. 11, pp. 1048-1051. https://doi.org/10.1002/humu.22856
University of Washington Center for Mendelian Genomics. Expanding the Molecular and Clinical Phenotype of SSR4-CDG. Human Mutation. 2015 Nov 1;36(11):1048-1051. https://doi.org/10.1002/humu.22856
University of Washington Center for Mendelian Genomics. / Expanding the Molecular and Clinical Phenotype of SSR4-CDG. In: Human Mutation. 2015 ; Vol. 36, No. 11. pp. 1048-1051.
@article{12293c60b8ae4fc1b5966dca20ca0edc,
title = "Expanding the Molecular and Clinical Phenotype of SSR4-CDG",
abstract = "Congenital disorders of glycosylation (CDG) are a group of mostly autosomal recessive disorders primarily characterized by neurological abnormalities. Recently, we described a single CDG patient with a de novo mutation in the X-linked gene, Signal Sequence Receptor 4 (SSR4). We performed whole-exome sequencing to identify causal variants in several affected individuals who had either an undifferentiated neurological disorder or unsolved CDG of unknown etiology based on abnormal transferrin glycosylation. We now report eight affected males with either de novo (4) or inherited (4) loss of function mutations in SSR4. Western blot analysis revealed that the mutations caused a complete loss of SSR4 protein. In nearly all cases, the abnormal glycosylation of serum transferrin was only slightly above the accepted normal cutoff range.",
keywords = "Carbohydrate-deficient transferrin, Congenital disorders of glycosylation, Signal sequence receptor 4, SSR4, Translocon complex",
author = "{University of Washington Center for Mendelian Genomics} and Ng, {Bobby G.} and Kimiyo Raymond and Martin Kircher and Buckingham, {Kati J.} and Tim Wood and Jay Shendure and Nickerson, {Deborah A.} and Bamshad, {Michael J.} and Wong, {Jonathan T S} and Monteiro, {Fabiola Paoli} and Graham, {Brett H.} and Sheryl Jackson and Rebecca Sparkes and Scheuerle, {Angela E.} and Sara Cathey and Fernando Kok and Gibson, {James B.} and Freeze, {Hudson H.}",
year = "2015",
month = "11",
day = "1",
doi = "10.1002/humu.22856",
language = "English (US)",
volume = "36",
pages = "1048--1051",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "11",

}

TY - JOUR

T1 - Expanding the Molecular and Clinical Phenotype of SSR4-CDG

AU - University of Washington Center for Mendelian Genomics

AU - Ng, Bobby G.

AU - Raymond, Kimiyo

AU - Kircher, Martin

AU - Buckingham, Kati J.

AU - Wood, Tim

AU - Shendure, Jay

AU - Nickerson, Deborah A.

AU - Bamshad, Michael J.

AU - Wong, Jonathan T S

AU - Monteiro, Fabiola Paoli

AU - Graham, Brett H.

AU - Jackson, Sheryl

AU - Sparkes, Rebecca

AU - Scheuerle, Angela E.

AU - Cathey, Sara

AU - Kok, Fernando

AU - Gibson, James B.

AU - Freeze, Hudson H.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Congenital disorders of glycosylation (CDG) are a group of mostly autosomal recessive disorders primarily characterized by neurological abnormalities. Recently, we described a single CDG patient with a de novo mutation in the X-linked gene, Signal Sequence Receptor 4 (SSR4). We performed whole-exome sequencing to identify causal variants in several affected individuals who had either an undifferentiated neurological disorder or unsolved CDG of unknown etiology based on abnormal transferrin glycosylation. We now report eight affected males with either de novo (4) or inherited (4) loss of function mutations in SSR4. Western blot analysis revealed that the mutations caused a complete loss of SSR4 protein. In nearly all cases, the abnormal glycosylation of serum transferrin was only slightly above the accepted normal cutoff range.

AB - Congenital disorders of glycosylation (CDG) are a group of mostly autosomal recessive disorders primarily characterized by neurological abnormalities. Recently, we described a single CDG patient with a de novo mutation in the X-linked gene, Signal Sequence Receptor 4 (SSR4). We performed whole-exome sequencing to identify causal variants in several affected individuals who had either an undifferentiated neurological disorder or unsolved CDG of unknown etiology based on abnormal transferrin glycosylation. We now report eight affected males with either de novo (4) or inherited (4) loss of function mutations in SSR4. Western blot analysis revealed that the mutations caused a complete loss of SSR4 protein. In nearly all cases, the abnormal glycosylation of serum transferrin was only slightly above the accepted normal cutoff range.

KW - Carbohydrate-deficient transferrin

KW - Congenital disorders of glycosylation

KW - Signal sequence receptor 4

KW - SSR4

KW - Translocon complex

UR - http://www.scopus.com/inward/record.url?scp=84944168146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944168146&partnerID=8YFLogxK

U2 - 10.1002/humu.22856

DO - 10.1002/humu.22856

M3 - Article

C2 - 26264460

AN - SCOPUS:84944168146

VL - 36

SP - 1048

EP - 1051

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 11

ER -